Systemic and local antibody responses in elderly subjects given live or inactivated influenza A virus vaccines
- PMID: 2592535
- PMCID: PMC267105
- DOI: 10.1128/jcm.27.12.2666-2671.1989
Systemic and local antibody responses in elderly subjects given live or inactivated influenza A virus vaccines
Abstract
Intranasal live attenuated cold-adapted (ca) influenza A/Kawasaki/9/86 (H1N1) reassortant virus and parenteral inactivated influenza A/Taiwan/1/86 (H1N1) virus were given alone or in combination to 80 ambulatory elderly subjects. An enzyme-linked immunosorbent assay was used to measure hemagglutinin-specific (HA) antibodies in serum and nasal wash specimens collected before vaccination and 1 and 3 months later. Serum immunoglobulin G (IgG) and nasal wash IgA HA responses were elicited in 56 and 20%, respectively, of 25 inactivated-virus vaccinees and in 67 and 48%, respectively, of 27 recipients of both vaccines but in only 36 and 25%, respectively, of 28 vaccinees given live virus alone. Inactivated virus, administered alone or with live virus vaccine, induced higher titers of serum antibody than did the live virus alone. In contrast, nasal IgA HA antibody was elicited more often and in greater quantity by the vaccine combination than by either vaccine alone. Despite these differences, the peak titers of local antibody mounted by each group of vaccinees were similar. By 3 months postvaccination, serum IgG and nasal IgA HA antibody titers remained elevated above prevaccination levels in 50 and 17%, respectively, of the inactivated-virus vaccinees and in 46 and 23%, respectively, of recipients of both vaccines but in only 19 and 7%, respectively, of the live-virus and systemic antibodies, if vaccinees. The finding that live ca influenza A virus induced short-lived local and systemic antibodies, if confirmed, suggests that live virus vaccination may not be a suitable alternative or adjunct to inactivated virus vaccination for the elderly.
Similar articles
-
Development and persistence of local and systemic antibody responses in adults given live attenuated or inactivated influenza A virus vaccine.J Clin Microbiol. 1986 Jan;23(1):66-72. doi: 10.1128/jcm.23.1.66-72.1986. J Clin Microbiol. 1986. PMID: 3700610 Free PMC article.
-
In elderly persons live attenuated influenza A virus vaccines do not offer an advantage over inactivated virus vaccine in inducing serum or secretory antibodies or local immunologic memory.J Clin Microbiol. 1991 Mar;29(3):498-505. doi: 10.1128/jcm.29.3.498-505.1991. J Clin Microbiol. 1991. PMID: 2037667 Free PMC article. Clinical Trial.
-
Local and systemic antibody responses in high-risk adults given live-attenuated and inactivated influenza A virus vaccines.J Clin Microbiol. 1988 May;26(5):911-8. doi: 10.1128/jcm.26.5.911-918.1988. J Clin Microbiol. 1988. PMID: 3384914 Free PMC article.
-
Intranasal Inactivated Influenza Vaccines: a Reasonable Approach to Improve the Efficacy of Influenza Vaccine?Jpn J Infect Dis. 2016;69(3):165-79. doi: 10.7883/yoken.JJID.2015.560. Jpn J Infect Dis. 2016. PMID: 27212584 Review.
-
Intranasal Administration of Whole Inactivated Influenza Virus Vaccine as a Promising Influenza Vaccine Candidate.Viral Immunol. 2017 Jul/Aug;30(6):451-462. doi: 10.1089/vim.2017.0022. Epub 2017 Jun 26. Viral Immunol. 2017. PMID: 28650274 Review.
Cited by
-
Intranasal powder live attenuated influenza vaccine is thermostable, immunogenic, and protective against homologous challenge in ferrets.NPJ Vaccines. 2021 Apr 21;6(1):59. doi: 10.1038/s41541-021-00320-9. NPJ Vaccines. 2021. PMID: 33883559 Free PMC article.
-
Influenza vaccination in the elderly.Postgrad Med J. 1996 Jun;72(848):339-42. doi: 10.1136/pgmj.72.848.339. Postgrad Med J. 1996. PMID: 8758010 Free PMC article. Review.
-
Longitudinal assessment of human antibody binding to hemagglutinin elicited by split-inactivated influenza vaccination over six consecutive seasons.PLoS One. 2024 Jun 25;19(6):e0301157. doi: 10.1371/journal.pone.0301157. eCollection 2024. PLoS One. 2024. PMID: 38917104 Free PMC article.
-
Intranasal cold-adapted influenza virus vaccine combined with inactivated influenza virus vaccines: an extra boost for the elderly?Drugs Aging. 2004;21(6):349-59. doi: 10.2165/00002512-200421060-00001. Drugs Aging. 2004. PMID: 15084138 Review.
-
Inactivated and live-attenuated seasonal influenza vaccines boost broadly neutralizing antibodies in children.Cell Rep Med. 2022 Feb 3;3(2):100509. doi: 10.1016/j.xcrm.2022.100509. eCollection 2022 Feb 15. Cell Rep Med. 2022. PMID: 35243417 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous